| Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study AT van Oosterom, I Judson, J Verweij, S Stroobants, ED di Paola, ... The Lancet 358 (9291), 1421-1423, 2001 | 1595 | 2001 |
| Bone metastases: pathophysiology and management policy. OS Nielsen, AJ Munro, IF Tannock Journal of Clinical Oncology 9 (3), 509-524, 1991 | 689 | 1991 |
| Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial A Le Cesne, JY Blay, I Judson, A Van Oosterom, J Verweij, J Radford, ... Journal of Clinical Oncology 23 (3), 576-584, 2005 | 519 | 2005 |
| Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are … J Verweij, A van Oosterom, JY Blay, I Judson, S Rodenhuis, ... European Journal of Cancer 39 (14), 2006-2011, 2003 | 517 | 2003 |
| Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas M Van Glabbeke, J Verweij, I Judson, OS Nielsen, ... European Journal of Cancer 38 (4), 543-549, 2002 | 472 | 2002 |
| Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the … I Judson, JA Radford, M Harris, JY Blay, Q van Hoesel, A Le Cesne, ... European Journal of Cancer 37 (7), 870-877, 2001 | 452 | 2001 |
| Surgical treatment of lung metastases: the european organization for research and treatment of cancer‐soft tissue and bone sarcoma group study of 255 patients AN Van Geel, U Pastorino, KW Jauch, IR Judson, F Van Coevorden, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1996 | 415 | 1996 |
| Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases OS Nielsen, SM Bentzen, E Sandberg, CC Gadeberg, AR Timothy Radiotherapy and oncology 47 (3), 233-240, 1998 | 362 | 1998 |
| Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations M Nordsmark, J Alsner, J Keller, OS Nielsen, OM Jensen, MR Horsman, ... British journal of cancer 84 (8), 1070-1075, 2001 | 300 | 2001 |
| Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group AT van Oosterom, IR Judson, J Verweij, S Stroobants, H Dumez, ... European Journal of Cancer 38, S83-S87, 2002 | 283 | 2002 |
| A future for hyperthermia in cancer treatment? OS Nielsen, M Horsman, J Overgaard European Journal of Cancer 37 (13), 1587-1589, 2001 | 237 | 2001 |
| Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy JY Blay, M van Glabbeke, J Verweij, AT Van Oosterom, A Le Cesne, ... European Journal of Cancer 39 (1), 64-69, 2003 | 221 | 2003 |
| Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first-and second-line chemotherapy in advanced … AT Van Oosterom, HT Mouridsen, OS Nielsen, P Dombernowsky, ... European Journal of Cancer 38 (18), 2397-2406, 2002 | 215 | 2002 |
| Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group. E Work, OS Nielsen, SM Bentzen, K Fode, T Palshof Journal of clinical oncology 15 (9), 3030-3037, 1997 | 209 | 1997 |
| Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose … L Bastholt, M Dalmark, SB Gjedde, P Pfeiffer, D Pedersen, E Sandberg, ... Journal of clinical oncology 14 (4), 1146-1155, 1996 | 193 | 1996 |
| Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group OS Nielsen, I Judson, Q van Hoesel, A Le Cesne, HJ Keizer, JY Blay, ... European journal of cancer 36 (1), 61-67, 2000 | 190 | 2000 |
| Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases ML Jensen, B Schumacher, OM Jensen, OS Nielsen, J Keller The American journal of surgical pathology 22 (5), 588-594, 1998 | 184 | 1998 |
| The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas M Nordsmark, M Høyer, J Keller, OS Nielsen, OM Jensen, J Overgaard International Journal of Radiation Oncology* Biology* Physics 35 (4), 701-708, 1996 | 182 | 1996 |
| Preoperative and postoperative irradiation of soft tissue sarcomas: effect on radiation field size OS Nielsen, B Cummings, B O'Sullivan, C Catton, RS Bell, VL Fornasier International Journal of Radiation Oncology* Biology* Physics 21 (6), 1595-1599, 1991 | 155 | 1991 |
| Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor … A Flyvbjerg, O Mogensen, B Mogensen, OS Nielsen The Journal of Clinical Endocrinology & Metabolism 82 (7), 2308-2313, 1997 | 150 | 1997 |
Jean-yves BlayProfesseur de Cancérologie Centre Leon Berard & University Claude Bernard Lyon I在 lyon.unicancer.fr 的电子邮件经过验证
